GlassScriptPhysician profile
Timir Kumar Paul
NPI 1336337195
$5,913.53
in general payments reported to CMS, 2019-2025
22 companies · $557 in 2025
The $557 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,011 · 2020: $120 · 2021: $732 · 2022: $1,532 · 2023: $826 · 2024: $136 · 2025: $557.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,518.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,518.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $1,630.67 | 2019 | |
| Abbott Laboratories | $717.51 | 2019-2025 | Amplatzer Amulet, Pressurewire, Architect |
| Boston Scientific Corporation | $681.67 | 2022-2025 | Watchman Access System, Avvigo Guidance System, Synergy |
| Abiomed | $524.47 | 2021-2022 | |
| Agepha Pharma Fz LLC | $310.86 | 2025 | Lodoco |
| Shockwave Medical, INC | $253.49 | 2021-2022 | |
| Cardiovascular Systems INC. | $249.62 | 2019-2022 | |
| Edwards Lifesciences Corporation | $220.66 | 2019-2021 | |
| Inari Medical, INC. | $208.17 | 2022 | |
| Terumo Medical Corporation | $162.46 | 2023 | Angio-Seal, Glidewire, Heartrail |
| Siemens Medical Solutions USA, INC. | $160.65 | 2023 | Biograph Horizon-3r |
| Medtronic, INC. | $153.98 | 2021-2023 | Onyx Frontier |
| Biotronik INC. | $151.98 | 2022 | |
| Janssen Pharmaceuticals, INC | $151.19 | 2021 | |
| Amgen INC. | $79.11 | 2019-2025 | Repatha |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $75.00 | 2019 | |
| Novartis Pharmaceuticals Corporation | $48.77 | 2021 | |
| Inspire Medical Systems, INC. | $42.23 | 2023 | Inspire |
| Boehringer Ingelheim Pharmaceuticals, INC. | $26.78 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $23.17 | 2020-2021 | |
| Penumbra, INC. | $22.00 | 2022 | |
| Medtronic Vascular, INC. | $19.09 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timir Paul listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.